Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials

INTRODUCTION: As the number of Alzheimer's disease (AD) prevention studies grows, many individuals will need to learn their genetic and/or biomarker risk for the disease to determine trial eligibility. An alternative to traditional models of genetic counseling and disclosure is needed to provid...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (N Y)
Autors principals: Langlois, Carolyn M., Bradbury, Angela, Wood, Elisabeth M., Roberts, J. Scott, Kim, Scott Y.H., Riviere, Marie-Emmanuelle, Liu, Fonda, Reiman, Eric M., Tariot, Pierre N., Karlawish, Jason, Langbaum, Jessica B.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Featured Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944715/
https://ncbi.nlm.nih.gov/pubmed/31921963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.09.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars